382 related articles for article (PubMed ID: 8604833)
1. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.
Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G
Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
Knorr C; Meyer T; Janssen T; Goehl J; Hohenberger W
Eur J Surg Oncol; 2006 Mar; 32(2):224-7. PubMed ID: 16289716
[TBL] [Abstract][Full Text] [Related]
3. Results of cisplatin hyperthermic isolation perfusion for stage IIIA and IIIAB extremity melanoma.
Fletcher WS; Pommier R; Small K
Melanoma Res; 1994 Mar; 4 Suppl 1():17-9. PubMed ID: 8038590
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities.
Boesch CE; Meyer T; Waschke L; Merkel S; Goehl J; Hohenberger W; Knorr C
Int J Hyperthermia; 2010 Feb; 26(1):16-20. PubMed ID: 20100048
[TBL] [Abstract][Full Text] [Related]
5. Long-term functional outcome after hyperthermic isolated limb perfusion (HILP).
Knorr C; Melling N; Goehl J; Drachsler T; Hohenberger W; Meyer T
Int J Hyperthermia; 2008 Aug; 24(5):409-14. PubMed ID: 18608587
[TBL] [Abstract][Full Text] [Related]
6. [Relations of chemotherapy-induced tumor necrosis to plasma platin concentration and primary tumor temperature in patients with osteosarcoma in the lower extremities treated by hyperthermic isolation limb perfusion with cisplatin].
Fan S; Yang D; Tao H; Ye Z; He R
Zhonghua Wai Ke Za Zhi; 2000 May; 38(5):336-9. PubMed ID: 11832050
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
[TBL] [Abstract][Full Text] [Related]
8. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS
Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.
Di Filippo F; Rossi CR; Santinami M; Cavaliere F; Garinei R; Anzà M; Perri P; Botti C; Di Angelo P; Pasqualoni R; Di Filippo S
In Vivo; 2006; 20(6A):739-42. PubMed ID: 17203758
[TBL] [Abstract][Full Text] [Related]
10. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.
Fraker DL; Alexander HR; Andrich M; Rosenberg SA
Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465
[TBL] [Abstract][Full Text] [Related]
11. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
12. Conventional isolated hyperthermic antiblastic perfusion in the treatment of recurrent limb melanoma.
Decian F; Mondini G; Demarchi R; Muzio G; Sementa A; Bocchio MM; Spirito C; Simoni G; Civalleri D
Anticancer Res; 1996; 16(4A):2017-24. PubMed ID: 8712736
[TBL] [Abstract][Full Text] [Related]
13. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
Cornett WR; McCall LM; Petersen RP; Ross MI; Briele HA; Noyes RD; Sussman JJ; Kraybill WG; Kane JM; Alexander HR; Lee JE; Mansfield PF; Pingpank JF; Winchester DJ; White RL; Chadaram V; Herndon JE; Fraker DL; Tyler DS;
J Clin Oncol; 2006 Sep; 24(25):4196-201. PubMed ID: 16943537
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermic perfusion of recurrent malignant melanoma on the extremities.
Hafström L; Jönsson PE
Acta Chir Scand; 1980; 146(5):313-8. PubMed ID: 7468061
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic isolated regional perfusion of the limb with carboplatin.
Daryanani D; de Vries EG; Guchelaar HJ; van Weerden TW; Hoekstra HJ
Eur J Surg Oncol; 2000 Dec; 26(8):792-7. PubMed ID: 11087648
[TBL] [Abstract][Full Text] [Related]
16. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
Binder J; Henneking K
Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
[TBL] [Abstract][Full Text] [Related]
17. [Hyperthermic regional perfusion in malignant melanoma of an extremity].
Andersson AP; Drzewiecki KT
Ugeskr Laeger; 1992 Oct; 154(41):2815-9. PubMed ID: 1413222
[TBL] [Abstract][Full Text] [Related]
18. Results of hyperthermic perfusion for melanoma of the extremities.
Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF
Surg Gynecol Obstet; 1975 Mar; 140(3):339-48. PubMed ID: 1114425
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of malignant melanoma of the limbs combined with thermochemotherapy under extracorporeal circulation].
Truchetet F; Grosshans E; Kretz JG; Bartier JC; Laplanche G
Ann Dermatol Venereol; 1988; 115(5):573-85. PubMed ID: 3195954
[TBL] [Abstract][Full Text] [Related]
20. [Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].
Schraffordt Koops H; Oldhoff J
Hautarzt; 1982 Sep; 33(9):506-10. PubMed ID: 7174325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
